Filtered By:
Management: National Institutes of Health (NIH)
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 21810 results found since Jan 2013.
NIH Awards Will Fund Post-Treatment Lyme Disease Syndrome Research
July 21, 2023 -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded five projects for research to better understand Post-treatment Lyme Disease Syndrome (PTLDS), which is a...
Source: Drugs.com - Clinical Trials - July 21, 2023 Category: Pharmaceuticals Source Type: clinical trials
News at a glance: Ben Franklin ’s anticounterfeiting, science’s English language barrier, and disclosing stigmatized identities to students
INFECTIOUS DISEASES
Drugmaker expands access to TB drug
A man with tuberculosis undergoes an electrocardiogram at an Indian clinic that treats drug-resistant TB.
UNIT PARANJPE/AFP/GETTY IMAGES
The pharmaceutical company Johnson & Johnson (J&J) last week agreed to help make a therapy critical to fighting drug-resistant tuberculosis (TB) more widely available and affordable. J&J said it would allow competitors to market generic versions of the lifesaving drug, bedaquiline, in 44 low- and middle-income countries (LMICs) where the company has active patents. The ...
Source: ScienceNOW - July 20, 2023 Category: Science Source Type: news
Omega-3 fatty acids appear promising for maintaining lung health
NIH-funded study supports new role for nutrient found in fish, dietary supplements.
Source: National Institutes of Health (NIH) News Releases - July 20, 2023 Category: American Health Source Type: news
The original GOP revolutionary championed health research, but the pandemic has changed even Newt Gingrich
Former Speaker Newt Gingrich has, like the current crop of House Republicans, turned on the National Institutes of Health. A generation ago, Gingrich led a GOP Congress that dramatically increased NIH funding, believing it would drive innovation in medicine, life-saving treatments and job-creating…#newtgingrich #republicans #nih #politico #republicanparty #georgia #anthonyfauci #rosadelauro #erikfatemi #senateappropriations
Source: Reuters: Health - July 20, 2023 Category: Consumer Health News Source Type: news
Influenza Pathogenesis and Therapeutics in Vulnerable Populations
Established in 1950 in honor of former NIH Director Rolla E. Dyer, M.D., a noted authority on infectious diseases, this lectureship, now part of the Wednesday Afternoon Lecture Series, features internationally renowned researchers who have contributed substantially to medical as well as biological knowledge of infectious diseases. The Dyer Lecture is the oldest continuous lecture series at the NIH.
Stacey Schultz-Cherry, PhD, is a Full Member and Professor in the Department of Infectious Diseases at St Jude Children ’ s Research Hospital in Memphis, TN as well as Senior Associate Dean for the St Jude Graduate School of...
Source: Videocast - All Events - July 19, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
The Great Escape: Phage Lysis and Its Control
The National Institute of General Medical Sciences (NIGMS) established the DeWitt Stetten Jr. Lecture in 1982 on the occasion of the institute ’ s 20th anniversary in honor of its third director, DeWitt “ Hans ” Stetten, Jr., M.D., Ph.D. Stetten was an esteemed biomedical research and administrator who had a varied biomedical career at and beyond the NIH. He first came to NIH in 1954 as associate director of intramural research at what was then called the National Institute of Arthritis and Metabolic Diseases. Having made his imprint there, he left the NIH to serve as dean of the Rutgers University Medical School fro...
Source: Videocast - All Events - July 19, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
Women treated for breast cancer may age faster than cancer-free women
NIH study finds radiation shows strongest association, less for surgery and endocrine treatments.
Source: National Institutes of Health (NIH) News Releases - July 19, 2023 Category: American Health Source Type: news
New atlas of human kidney cells to help unlock kidney disease research
NIH-funded effort provides interactive resource for global research community.
Source: National Institutes of Health (NIH) News Releases - July 19, 2023 Category: American Health Source Type: news
Shortened TB Regimen Not Effective
A clinical trial testing a 3-month tuberculosis (TB) treatment has stopped enrollment at 104 people after participants receiving the regimen experienced ongoing or recurring TB above the rates deemed acceptable in the study ’s protocol, the US National Institutes of Health (NIH) announced. The study’s researchers, who launched the trial in November 2021, had expected to enroll a total of 185 participants across Haiti, India, Malawi, South Africa, and Zimbabwe.
Source: JAMA - Journal of the American Medical Association - July 19, 2023 Category: General Medicine Source Type: research
NIH HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (RFA-AT-24-003) Technical Assistance Webinar
The National Institutes of Health (NIH) invites you to join us on Wednesday, August 9, 2023, at 1 p.m. ET for a technical assistance webinar to learn more about RFA-AT-24-003 - " HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) " (REISSUE).
This webinar is provided for potential applicants who want to learn details about this exciting and unique notice of funding opportunity focusing on myofascial tissues for clinical pain management. Highlights of this webinar include an overview of the scope and im...
Source: Videocast - All Events - July 18, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
Few Surgeon-Scientists Continue to Receive NIH Funding After Training
MONDAY, July 17, 2023 -- Surgery trainees who obtain National Institutes of Health (NIH) F32 grants during training are less likely to receive any form of NIH funding in the future compared with internal medicine colleagues receiving F32 grants,...
Source: Drugs.com - Pharma News - July 17, 2023 Category: Pharmaceuticals Source Type: news
Thrombectomy vs. medical management for large vessel occlusion strokes with minimal symptoms
Exp Ther Med. 2023 Jun 23;26(2):377. doi: 10.3892/etm.2023.12076. eCollection 2023 Aug.ABSTRACTPatients with acute ischemic stroke (AIS) presenting mild symptoms with a low National Institutes of Health Stroke Scale (NIHSS) score ≤8 and also found to have an intracranial large vessel occlusion (LVO) undergo endovascular thrombolysis (ET) or medical management alone. The current study aimed to evaluate the safety and effectiveness of medical management vs. ET therapy among patients with mild AIS symptoms (NIHSS score ≤8) accompanied by LVO. The present meta-analysis included articles involving mild AIS, LVO, thrombectom...
Source: Experimental and Therapeutic Medicine - July 17, 2023 Category: General Medicine Authors: Iason-Stefanos Anagnostopoulos Vasiliki Epameinondas Georgakopoulou Ilias Trakas Petros Papalexis Nikolaos Trakas Demetrios A Spandidos George Fotakopoulos Source Type: research
